ISSUER PROFILE · CIK 0001853921 · CUSIP 811033109
Scribe Therapeutics, Inc.SCTX
3 13D/G filings
3 distinct filers
11 insider transactions (365d)
Cross-Reference Snapshot
Activist filings
3
3 SCHEDULE 13D
Distinct filers
3
multi-activist cluster
Insiders (365d)
11
11 buys · 0 sales
Latest short DTC
2.63
as of 2026-08-31
13D/G Filings Timeline · 3 total
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-07-28 |
Aghazadeh Behzad |
director, 10%+ |
Buy |
7,905 |
$18.25 |
$144K |
| 2026-07-24 |
Aghazadeh Behzad |
director, 10%+ |
Buy |
2,333,333 |
$15.00 |
$35.00M |
| 2026-07-24 |
Aghazadeh Behzad |
director, 10%+ |
Buy |
50,000 |
$22.31 |
$1.12M |
| 2026-07-23 |
Lucas Svetlana |
officer |
Buy |
3,000 |
$15.00 |
$45K |
| 2026-07-23 |
Lucas Svetlana |
officer |
Award |
109,426 |
$15.00 |
$1.64M |
| 2026-07-23 |
Oakes Benjamin L. |
director, officer |
Award |
264,784 |
$15.00 |
$3.97M |
| 2026-07-23 |
Oakes Benjamin L. |
director, officer |
Award |
429,599 |
$15.00 |
$6.44M |
| 2026-07-23 |
GORDON CARL L |
director |
Award |
14,725 |
$15.00 |
$221K |
| 2026-07-23 |
Watson James Dean |
director |
Award |
14,725 |
$15.00 |
$221K |
| 2026-03-13 |
Lucas Svetlana |
officer |
Award |
9,547 |
$19.13 |
$183K |
| 2026-03-13 |
Oakes Benjamin L. |
director, officer |
Award |
12,969 |
$19.13 |
$248K |
FINRA Short Interest History
| Settlement | Short Interest | Days to Cover | % Δ vs prior |
|---|
| 2026-08-31 |
778,191 |
2.63 |
+173.3% |
| 2026-08-14 |
284,711 |
2.14 |
+8.2% |
| 2026-07-31 |
263,070 |
1.34 |
+100.0% |
Alert me when any activist files on Scribe Therapeutics, Inc.
Free. We email you when criteria match. One-click unsubscribe in every email.
Track every activist who touches this name.
Custom alerts · full feed · daily intelligence · API. From $49/mo.
See pricing →